| Stem definition | Drug id | CAS RN |
|---|---|---|
| 813 | 17598-65-1 |
| Dose | Unit | Route |
|---|---|---|
| 1 | mg | P |
| Property | Value | Reference |
|---|---|---|
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.02 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA | NOVARTIS |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | C01AA07 | CARDIOVASCULAR SYSTEM CARDIAC THERAPY CARDIAC GLYCOSIDES Digitalis glycosides |
| MeSH PA | D000889 | Anti-Arrhythmia Agents |
| MeSH PA | D002316 | Cardiotonic Agents |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D020011 | Protective Agents |
| CHEBI has role | CHEBI:25212 | metabolites |
| CHEBI has role | CHEBI:38070 | antiarrhythmic agent |
| CHEBI has role | CHEBI:38147 | cardiotonic drugs |
| CHEBI has role | CHEBI:63510 | sodium-potassium adenosine triphosphatase inhibitors |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 13.68 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Sodium/potassium-transporting ATPase | Transporter | INHIBITOR | CHEMBL | CHEMBL |
| ID | Source |
|---|---|
| 4018753 | VUID |
| N0000147056 | NUI |
| D01240 | KEGG_DRUG |
| 3248 | RXNORM |
| 4018753 | VANDF |
| C0011689 | UMLSCUI |
| CHEBI:31468 | CHEBI |
| CHEMBL1614 | ChEMBL_ID |
| D003892 | MESH_DESCRIPTOR_UI |
| DB01078 | DRUGBANK_ID |
| 6806 | IUPHAR_LIGAND_ID |
| 1581 | INN_ID |
| YGY317RK75 | UNII |
| 28620 | PUBCHEM_CID |
| 000595 | NDDF |
| 16214005 | SNOMEDCT_US |
| 398962006 | SNOMEDCT_US |
None